Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder
Leslie Citrome, Christopher Reist, Liisa Palmer, Leslie B. Montejano, Gregory Lenhart, Brian Cuffel, James Harnett, Kafi N. SandersТом:
115
Рік:
2009
Мова:
english
DOI:
10.1016/j.schres.2009.09.023
Файл:
PDF, 300 KB
english, 2009